Ovarian cancer G protein coupled receptor 1 suppresses cell migration of MCF7 breast cancer cells via a Gα12/13-Rho-Rac1 pathway

Journal of Molecular Signaling

Volumn 8, Issue , 2013, Pages

  Li, Jing ^a   Guo, Bin ^a   Wang, Jing ^a   Cheng, Xiaoyan ^a   Xu, Yan ^b   Sang, Jianli ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Cell migration; G 12 13; MCF7 cells; OGR1; Rac1; Rho

Indexed keywords

EID: 84877308342     PISSN: None     EISSN: 17502187     Source Type: Journal    
DOI: 10.1186/1750-2187-8-6     Document Type: Article

References (41)

1. Im DS. Two ligands for a GPCR, proton vs lysolipid. Acta Pharmacol Sin 2005, 26(12):1435-1441. 10.1111/j.1745-7254.2005.00237.x, 16297340.
2. Tomura H. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: A novel type of multi-functional receptors. Cell Signal 2005, 17(12):1466-1476. 10.1016/j.cellsig.2005.06.002, 16014326.
3. Ludwig MG. Proton-sensing G-protein-coupled receptors. Nature 2003, 425(6953):93-98. 10.1038/nature01905, 12955148.
4. Murakami N. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 2004, 279(41):42484-42491. 10.1074/jbc.M406561200, 15280385.
5. Wang JQ. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 2004, 279(44):45626-45633. 10.1074/jbc.M406966200, 15326175.
6. Li H. Abnormalities in Osteoclastogenesis and Decreased Tumorigenesis in Mice Deficient for Ovarian Cancer G Protein-Coupled Receptor 1. PLoS One 2009, 4(5):e5705. 10.1371/journal.pone.0005705, 2684630, 19479052.
7. Yang LV. Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor. Mol Cell Biol 2007, 27(4):1334-1347. 10.1128/MCB.01909-06, 1800706, 17145776.
8. Radu CG. Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-Cell death-associated gene 8 receptor. Mol Cell Biol 2006, 26(2):668-677. 10.1128/MCB.26.2.668-677.2006, 1346912, 16382156.
9. Xu Y, Zhu K. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 (vol 2, pg 261, 2000). Nat Cell Biol 2000, 2(8):E146-E146.
10. Zhu K. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. (Retraction of vol 276, pg 41325, 2001). J Biol Chem 2005, 280(52):43280-43280.
11. Im DS. Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol 2001, 153(2):429-434. 10.1083/jcb.153.2.429, 2169470, 11309421.
12. Obinata H. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem 2005, 280(49):40676-40683. 10.1074/jbc.M507787200, 16236715.
13. Singh LS. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst 2007, 99(17):1313-1327. 10.1093/jnci/djm107, 17728215.
14. Kim K. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. FASEB J 2005, 19(2):819.
15. Hasskarl J, Kaufmann M, Schmid HA. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors. Future Oncol 2011, 7(7):895-913. 10.2217/fon.11.66, 21732759.
16. Ren J, Zhang L. Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells. Chin Med J 2011, 124(9):1327-1332.
17. Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006, 16(10):522-529. 10.1016/j.tcb.2006.08.006, 16949823.
18. Kraynov VS. Localized Rac activation dynamics visualized in living cells. Science 2000, 290(5490):333-337. 10.1126/science.290.5490.333, 11030651.
19. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004, 265(1):23-32. 10.1016/j.ydbio.2003.06.003, 14697350.
20. Rottner K, Hall A, Small JV. Interplay between Rac and Rho in the control of substrate contact dynamics. Curr Biol 1999, 9(12):640-648. 10.1016/S0960-9822(99)80286-3, 10375527.
21. Beningo KA. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J Cell Biol 2001, 153(4):881-887. 10.1083/jcb.153.4.881, 2192381, 11352946.
22. Munevar S, Wang YL, Dembo M. Distinct roles of frontal and rear cell-substrate adhesions in fibroblast migration. Mol Biol Cell 2001, 12(12):3947-3954. 60767, 11739792.
23. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001, 12(9):2711-2720. 59706, 11553710.
24. Wang HR. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003, 302(5651):1775-1779. 10.1126/science.1090772, 14657501.
25. Worthylake RA, Burridge K. RhoA and ROCK promote migration by limiting membrane protrusions. J Biol Chem 2003, 278(15):13578-13584. 10.1074/jbc.M211584200, 12574166.
26. Kozma R. The Ras-related protein cdc42hs and bradykinin promote formation of peripheral actin microspikes and filopodia in swiss 3t3 fibroblasts. Mol Cell Biol 1995, 15(4):1942-1952. 230420, 7891688.
27. Nobes CD, Hall A. Rho, Rac, and Cdc42 Gtpases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia. Filopodia Cell 1995, 81(1):53-62.
28. Seifert A. TCDD induces cell migration via NFATc1/ATX-signaling in MCF-7 cells. Toxicol Lett 2009, 184(1):26-32. 10.1016/j.toxlet.2008.10.026, 19028555.
29. Sarkar S. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett 2005, 579(24):5313-5317. 10.1016/j.febslet.2005.08.055, 16194537.
30. Wyder L. Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor. Angiogenesis 2011, 14(4):533-544. 10.1007/s10456-011-9238-9, 22045552.
31. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002, 2(2):133. 10.1038/nrc725, 12635176.
32. Sugimoto N. Inhibitory and stimulatory regulation of Rac and cell motility by the G(12/13)-Rho and G(i) pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003, 23(5):1534-1545. 10.1128/MCB.23.5.1534-1545.2003, 151702, 12588974.
33. Arikawa K. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P(2) G protein-coupled receptor - Requirement of inhibition of cellular Rac activity. J Biol Chem 2003, 278(35):32841-32851. 10.1074/jbc.M305024200, 12810709.
34. Malchnkhuu E. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem Biophys Res Commun 2008, 366(4):963-968. 10.1016/j.bbrc.2007.12.054, 18088600.
35. Lepley D. The G protein-coupled receptor S1P(2) regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 2005, 65(9):3788-3795. 10.1158/0008-5472.CAN-04-2311, 15867375.
36. Sanchez T. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci USA 2005, 102(12):4312-4317. 10.1073/pnas.0409784102, 555509, 15764699.
37. Takashima S. G(12/13) and G(q) mediate S1P(2)-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc Res 2008, 79(4):689-697. 10.1093/cvr/cvn118, 18480127.
38. Ortiz-Lopez L. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009, 46(1):15-21. 10.1111/j.1600-079X.2008.00600.x, 18482340.
39. Tabu K. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA. Mol Cancer Res 2007, 5(10):1099-1109. 10.1158/1541-7786.MCR-07-0096, 17951409.
40. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth-factors. Cell 1992, 70(3):389-399. 10.1016/0092-8674(92)90163-7, 1643657.
41. Mogi C. Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. J Pharmacol Sci 2005, 99(2):160-167. 10.1254/jphs.FP0050599, 16210776.